ArticleThe Journal of infectious diseases2023

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.

Hope R Lapointe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.